Company / EPS (Diluted)
Lunai Bioworks Inc. EPS (Diluted) History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.18
FY2017
5-year range
-$0.40 / $0.00
FY2013-FY2017
Trend
+43.8%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.40 to $-0.18 over the past 3 years.
Based on SEC 10-K filings.
-0.18 in FY2017.
Improved from $-0.40 to $-0.18 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, eps (diluted) increased 43.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$0.18 | +43.8% |
| FY2016 | -$0.32 | +20.0% |
| FY2014 | -$0.40 | - |
| FY2011 | $0.00 | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026